Depo-Provera Brain Tumor (Meningioma)
In litigation
Mass-tort payouts ($50k+)
mass_tort · pharma
Depo-Provera brain tumor (meningioma) - MDL 3140 consolidated in N.D. Florida, litigation ramping
Eligibility hint
Received two or more Depo-Provera birth-control injections and were later diagnosed with a meningioma or other brain tumor
Pfizer faces a fast-growing wave of lawsuits alleging its injectable contraceptive Depo-Provera (medroxyprogesterone acetate) causes intracranial meningioma, a brain tumor. A 2024 BMJ study found prolonged use was associated with a materially elevated meningioma risk, and plaintiffs allege Pfizer failed to warn US users despite carrying such warnings abroad. The federal cases were consolidated in February 2025 as MDL No. 3140 in the Northern District of Florida before Judge M. Casey Rodgers; bellwether selection and discovery are underway and no settlement exists yet. Eligibility centers on repeated Depo-Provera use and a meningioma diagnosis.
Connected settlement administrations (1)
- Depo-Provera Brain Tumor Lawsuits
Brands:
pfizerpharmacia & upjohngreenstone
Products: depo-proveradepo proveramedroxyprogesteronemedroxyprogesterone acetatebirth control shotcontraceptive injection
Products: depo-proveradepo proveramedroxyprogesteronemedroxyprogesterone acetatebirth control shotcontraceptive injection
Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.